The next era of medicine is being built now.

Bioverge partners with visionary scientists and entrepreneurs building breakthrough biotechnologies with the potential to transform human health.

40

PRIVATE INVESTMENTS

LIQUIDITY EVENTS

YEARS OF EXPERIENCE

MISSION

ADVANCING HUMAN HEALTH

TECHNOLOGIES SHAPING THE FUTURE OF MEDICINE

Precision psychiatry powered by neuroscience and biomarkers. IPO in 2024.

NEUROSCIENCE

Using AI-powered tools to translate nature’s hidden chemistry into new medicines.

AI-enabled Drug Discovery

Harnessing next-generation oncolytic immunotherapies to treat solid tumors and metastatic cancer.

Immunotherapy

Developing the first personalized cell therapies for neurodegenerative diseases.

NEUROSCIENCE

Developing fully implantable bioartificial kidneys. Acquired by United Therapeutics.

Regenerative medicine

SELECT PORTFOLIO COMPANIES

Our mission is to extend and improve human life by investing in breakthrough biotechnologies with the potential to create lasting impact.